Company Overview and News

0
Manitou Gold Provides Exploration Update for Goudreau Area Properties

2018-07-16 globenewswire
SUDBURY, Ontario, July 16, 2018 (GLOBE NEWSWIRE) -- Manitou Gold Inc. (TSX-V:MTU) (the “Company” or “Manitou”) is pleased to provide an update on exploration and related activities for its Goudreau area properties.
AGI RIC MTU AMGGF RIC MNTUF ARNGF AGI AR

0
Riverside Signs New Partnership Agreement to Advance La Silla and Provides Glor Project Update

2018-07-11 globenewswire
VANCOUVER, British Columbia, July 11, 2018 (GLOBE NEWSWIRE) -- Riverside Resources Inc. ("Riverside" or the "Company") (TSX-V:RRI), and Sinaloa Resources Inc. (“Sinaloa”) is pleased to jointly announce that they have signed a letter of intent (the “LOI”) whereby Sinaloa can earn up to 100% interest in Riverside’s La Silla Project (the “Project”) located in Sinaloa, Mexico. The Project includes 2,071 hectares situated along the same regional trend and with the mineralization style as First Majestic’s San Dimas mine.
CAGDF RRI CG ARNGF AR RVSDF

0
Sonoro Appoints Mel Herdrick as V.P., Exploration

2018-06-04 globenewswire
VANCOUVER, British Columbia, June 04, 2018 (GLOBE NEWSWIRE) -- Sonoro Metals Corp., (“Sonoro” or the “Company”) (TSX-V:SMO) (OTCQB:SMOFF), announces the appointment of Mel Herdrick as Vice-President, Exploration. Mr. Herdrick is a professional geologist with 45 years of exploration and mine related experience in the United States and Mexico. His experience includes 10 years as Chief Geologist for Phelps Dodge, Mexico and 7 years as Vice President, Exploration for Pediment Gold in Mexico until its takeover by Argonaut Gold in 2011.
BGMNF ARNGF SMO SMOFF AR

38
10 Best Risk/Reward Leveraged Gold Stocks

2018-06-01 seekingalpha
Below is a list of 10 quality gold producers. I have selected them as the best risk/reward leveraged gold stocks. All of these should outperform the price of gold if it rises. In fact, I expect all of these stocks to double in value if gold reaches $1,600. These are the stocks that you want to own if you are looking for high returns if gold prices start trending. Also, if you are looking for a way to hedge against a market crash, then these stocks offer a potential hedge.
NGDAF ARNGF NGD TGD MUX.RTWI HUMRF DGC EDVVF PMNXF GCM.WT.A PRU MUX AR HTXFF HUM EDV RPM NGD ALO MUX TPWRF WDO EDVMF RPMGD DRGDF RPMGF PRU TPRFF GCM TMM EVR WDOFF

0
Sonoro Adds Tres Amigos Concession to Cerro Caliche

2018-05-29 globenewswire
VANCOUVER, British Columbia, May 29, 2018 (GLOBE NEWSWIRE) -- Sonoro Metals Corp., (“Sonoro”) (TSXV:SMO) (OTCQB:SMOFF), announces that its Mexican subsidiary, Minera Mar De Plata, SA de C.V. has executed a formal option agreement (the “Tres Amigos Option Agreement”) with two residents of Magdalena de Kino, Sonora, Mexico (the “Vendors”), to acquire a 100% interest in the 20 hectare Tres Amigos concession (“Tres Amigos”) located contiguous to the recently-acquired Cerro Caliche concessions in the prolific Cucurpe Sonora Mega-district of Sonora, Mexico.
CGEKF BGMNF GGAZF GGA ARNGF SMO SMOFF CGE AR

15
Manitou Gold Commences Field Exploration at its Goudreau Properties

2018-05-09 globenewswire
SUDBURY, Ontario, May 09, 2018 (GLOBE NEWSWIRE) -- Manitou Gold Inc. (TSX-V:MTU) (the “Company” or “Manitou”) is pleased to announce receipt of final reports on the magnetic (“MAG”), induced polarization (“IP”) and soil gas hydrocarbon (“SGH”) surveys completed on its 100% owned “Goudreau Patents.” The Goudreau Patents property consists of four surface and mining rights patents, covering an area of approximately 160 acres and is located less than 2 kms east of the past producing Edwards and Cline mine properties, within the Goudreau-Lochalsh Deformation Zone (the “GLDZ”).
AGI RIC MTU AMGGF RIC MNTUF ARNGF AGI AR

0
Argonaut Gold Announces Results of Annual and Special Meeting of Shareholders

2018-05-01 globenewswire
TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Argonaut Gold Inc. (TSX:AR) ("Argonaut", "Argonaut Gold" or the "Corporation"; TSX:AR) is pleased to announce the results of its annual meeting of shareholders (the "Meeting") held May 1, 2018.
ARNGF AR

15
Manitou Gold Signs Binding Agreement to Acquire Goudreau-Lochalsh “Rockstar” Property

2018-03-21 globenewswire
SUDBURY, Ontario, March 21, 2018 (GLOBE NEWSWIRE) -- Manitou Gold Inc. (TSX-V:MTU) (the “Company” or “Manitou”) announces that it has entered into a binding purchase agreement with Argo Gold Inc. (the “Vendor”) to purchase the property known as the “Rockstar” Property, comprised of 16 unpatented mining claims located in Jacobson and Riggs Townships, Ontario (collectively, the “Property”).
AGI RIC MTU AMGGF RIC MNTUF ARNGF AGI AR

0
Sonoro Closes Cerro Caliche Expansion Agreement

2018-03-20 globenewswire
VANCOUVER, British Columbia, March 20, 2018 (GLOBE NEWSWIRE) -- Sonoro Metals Corp., (“Sonoro”) (TSXV:SMO) (OTCQB:SMOFF), announces that its Mexican subsidiary, Minera Mar De Plata, SA de C.V. has executed a formal option agreement (the “Rosario Option Agreement”) with a resident of Tucson, Arizona (the “Vendor”), to acquire a 100% interest in the 403.5 hectare Rosario group of concessions (“Rosario”) on the terms initially disclosed in a news release dated March 5, 2018.
CGEKF BGMNF GGAZF GGA ARNGF SMO SMOFF CGE AR

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

8h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

9h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to TSX:AR / Argonaut Gold Inc. on message board site Silicon Investor.

LDSR - Landstar, Inc. Pennies Arent Dead
Quitting Cigarettes Point and Figure Charting
Technology Stocks u0026 Market Talk With Don Wolanchuk AMD, ARMH, INTC, NVDA
CCB vs ZEN truth board Buy and Sell Signals, and Other Market Perspectives
Computer Learning Dinou0027s Bar u0026 Grill